Antibodies to VLA-1
US9644030B2 · kind B2 · utility
0Cited by
44References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2015 |
| Grant date | May 9, 2017 |
| Priority date | — |
| Expiry date | Aug 9, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies that specifically bind to VLA-1 integrin and methods of using these antibodies to treat immunological disorders in a subject. Also included are crystal structures of complexes formed by VLA-1 antibodies and their ligands, and VLA-1 antagonists and agonists identified by using the structure coordinates of these structures.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.